A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML

Surface modification of tri-calcium phosphate nanoparticles by DOPE and/or anti-E6 antibody to enhance uptake of antisense of E6 mRNA

(2015) Ali Jebali et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Protamine–oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting

(2015) B. Scheicher et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides

(2015) Kariem Ezzat et al.   NANO LETTERS

Drug and gene co-delivery systems for cancer treatment

(2015) Zhe Yang et al.   Biomaterials Science

Nanocarriers in Gene Therapy: A Review

(2014) Hongpan Xu et al.   Journal of Biomedical Nanotechnology

Tumor-Targeting Transferrin Nanoparticles for Systemic Polymerized siRNA Delivery in Tumor-Bearing Mice

(2013) Ji Young Yhee et al.   BIOCONJUGATE CHEMISTRY

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

(2012) Patrick A. Ott et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells

(2011) Madaswamy S. Muthu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A Covalently Stabilized Lipid−Polycation−DNA (sLPD) Vector for Antisense Oligonucleotide Delivery

(2011) Xiaojuan Yang et al.   MOLECULAR PHARMACEUTICS

Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies

(2010) Peter S. Galatin et al.   INVESTIGATIONAL NEW DRUGS

Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides

(2009) R. Juliano et al.   MOLECULAR PHARMACEUTICS

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

(2008) S. L. Moulder et al.   CLINICAL CANCER RESEARCH

Therapeutic Nanoparticles for Drug Delivery in Cancer

(2008) K. Cho et al.   CLINICAL CANCER RESEARCH

Antitumor Activity of G3139 Lipid Nanoparticles (LNPs)

(2008) Xiaogang Pan et al.   MOLECULAR PHARMACEUTICS